Viela Bio Overview
- Founded
- 2017

- Status
- Public
- Employees
- 166

- Stock Symbol
- VIE

- Share Price
- $33.94
- (As of Thursday Closing)
Viela Bio General Information
Description
Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.
Contact Information
- One MedImmune Way
- First Floor, Area Two
- Gaithersburg, MD 20878
- United States
Viela Bio Timeline
Viela Bio Stock Performance
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$33.94 | $35.46 | $25.02 - $70.66 | $1.86B | 54.8M | 198K | -$2.46 |
Viela Bio Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
---|---|---|---|
EV | 1,112,152 | 1,652,631 | |
Revenue | 32,316 | 50,000 | 0 |
EBITDA | (132,073) | (89,507) | (192,294) |
Net Income | (128,849) | (86,429) | (190,270) |
Total Assets | 427,597 | 384,054 | 139,827 |
Total Debt | 974 | 0 | 0 |
Viela Bio Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Viela Bio‘s full profile, request access.
Request a free trialViela Bio Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
This information is available in the PitchBook Platform. To explore Viela Bio‘s full profile, request access.
Request a free trialViela Bio Comparisons
Industry
0000000
0000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialViela Bio Competitors (14)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
AnTolRx | Venture Capital-Backed | Cambridge, MA | 000 | 00000000000 | 000 | |
0000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 00000000 | 00000 |
0000000 | Venture Capital-Backed | Diepenbeek, Belgium | 0 | 000.00 | 00000000000 | 000.00 |
0000000 0000000000 | Venture Capital-Backed | San Mateo, CA | 00 | 00000 | 0000000000 0 | 00000 |
00000 0000 0000000 | Private Equity-Backed | Irving, TX | 0000 | 00000 | 0000000 0000 | 00000 |
Viela Bio Executive Team (8)
Viela Bio Board Members (14)
Name | Representing | Role | Since |
---|---|---|---|
Andreas Wicki Ph.D | Self | Board Member | 000 0000 |
Edward Hu Ph.D | 6 Dimensions Capital | Board Member | 000 0000 |
Pascal Soriot | Self | Board Member | 000 0000 |
Rachelle Jacques | Self | Board Member | 000 0000 |
Sean Tong | Self | Board Member | 000 0000 |
Viela Bio Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialViela Bio Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Viela Bio‘s full profile, request access.
Request a free trial